Literature DB >> 23711928

Hyperprolactinemia impairs object recognition without altering spatial learning in male rats.

Luz Torner1, Eréndira Tinajero, Naima Lajud, Andrés Quintanar-Stéphano, Esther Olvera-Cortés.   

Abstract

Prolactin (PRL) exerts protective effects on the hippocampus against chronic stress exposure, or kainic acid insults. Further, PRL null mice were recently shown to exhibit learning and memory deficits. These findings suggest the hippocampus as a PRL target. To test this hypothesis, we analyzed the hippocampal formation function in dependence of serum PRL concentrations. Male Sprague-Dawley rats were either transplanted with 2 pituitary homografts (HPRL) or had a sham operation (SHAM). Other groups were given vehicle (VEH) or daily injections of bromocriptine (BRC, 4mg/kg) to reduce PRL levels. The animals were sequentially subjected to the Morris water maze (MWM), the object recognition test and the elevated plus maze. PRL concentrations were measured with ELISAs. Learning curves from the MWM showed a progressive reduction in distance over time but no significant differences were found between SHAM and HPRL, or between BRC and VEH groups. Also, memory retrieval was not affected in the probe trial between each pair of groups. However, in the object recognition test the HPRL group failed to discriminate between novel and familiar objects, and the discrimination index was significantly reduced from that of the VEH group. BRC rats exhibited a reduced exploration of both objects compared to VEH, but had a discrimination index similar to VEH. No significant differences were observed in the EPM. In conclusion, high PRL levels impair object recognition but do not alter spatial learning. These results show for the first time that PRL impairs object recognition, and thus modulates non-spatial cognitive tasks.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bromocriptine; Cognition; Familiarity; Hippocampus; Morris water maze; Prolactin

Mesh:

Substances:

Year:  2013        PMID: 23711928     DOI: 10.1016/j.bbr.2013.05.031

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

Review 1.  Prolactin function and putative expression in the brain.

Authors:  Erika Alejandra Cabrera-Reyes; Ofelia Limón-Morales; Nadia Alejandra Rivero-Segura; Ignacio Camacho-Arroyo; Marco Cerbón
Journal:  Endocrine       Date:  2017-06-20       Impact factor: 3.633

Review 2.  Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.

Authors:  Meritxell Tost; José Antonio Monreal; Antonio Armario; Juan David Barbero; Jesús Cobo; Clemente García-Rizo; Miquel Bioque; Judith Usall; Elena Huerta-Ramos; Virginia Soria; Javier Labad
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859

3.  Cognitive Function and Serum Hormone Levels Are Associated with Gray Matter Volume Decline in Female Patients with Prolactinomas.

Authors:  Shun Yao; Jian Song; Junfeng Gao; Pan Lin; Ming Yang; Kashif Rafiq Zahid; Yan Yan; Chenglong Cao; Pan Ma; Hui Zhang; Zhouyue Li; Cheng Huang; Huichao Ding; Guozheng Xu
Journal:  Front Neurol       Date:  2018-01-29       Impact factor: 4.003

4.  Theta oscillations in prolactinomas: Neurocognitive deficits in executive controls.

Authors:  Chenglong Cao; Wen Wen; Binbin Liu; Pan Ma; Sheng Li; Guozheng Xu; Jian Song
Journal:  Neuroimage Clin       Date:  2020-09-30       Impact factor: 4.881

5.  Prolactin Reduces Hippocampal Parvalbumin and GABAA Receptor Expression in Female Mice.

Authors:  Susana Mellado; Beatriz Moreno-Ruiz; Sara Expósito; Miriam Fernández; Eduardo D Martín
Journal:  Neuroendocrinology       Date:  2021-10-19       Impact factor: 5.135

6.  Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis.

Authors:  Itziar Montalvo; Alfonso Gutiérrez-Zotes; Marta Creus; Rosa Monseny; Laura Ortega; Joan Franch; Stephen M Lawrie; Rebecca M Reynolds; Elisabet Vilella; Javier Labad
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

Review 7.  The search for new biomarkers for cognition in schizophrenia.

Authors:  Rafael Penadés; Clemente García-Rizo; Miquel Bioque; Alexandre González-Rodríguez; Bibiana Cabrera; Gisela Mezquida; Miquel Bernardo
Journal:  Schizophr Res Cogn       Date:  2015-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.